Weekly updateCompaniesRecruiting servicePost a job


    Company info:

  • 1-50
  • 2016
  • San Francisco, CA
  • 10-100M



Claim company profile

About company:

GenEdit is developing safe and efficient gene editing. Delivery remains a major challenge for gene editing therapies and limits the therapies’ performance. To improve delivery, GenEdit has developed a delivery platform called NanoGalaxy, which contains a library of unique non-viral, non-lipid, polymer nanoparticles that can be used as vectors for gene therapies. Polymer backbones are combined with small molecules to create a vast polymer diversity which GenEdit screens. Diversity in charge, size and composition offers a unique array of properties that affect the tissue-targeting specificity and durability. GenEdit is primarily interested in the lung, CNS and immune system for tissue targeting. By targeting these tissues selectively, GenEdit aids in the development of therapeutics for patients with high unmet medical need.


Head of Platform
San Francisco, CA|33 days ago
Research Associate II/Sr. Research Associate
San Francisco, CA|77 days ago
Accounting Clerk
San Francisco, CA|77 days ago
Research Associate/Sr. Research Associate
South San Francisco, CA/ On-site|99 days ago

© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com